share_log

Alphabet To $136? Plus This Analyst Slashes PT On United Natural Foods

Alphabet To $136? Plus This Analyst Slashes PT On United Natural Foods

Alphabet涨到136美元?此外,这位分析师大幅抨击联合天然食品公司的PT
Benzinga Real-time News ·  2022/09/28 15:02
  • Truist Securities cut the price target on Alphabet Inc. (NASDAQ:GOOGL) from $145 to $136. Truist Securities analyst Youssef Squali maintained a Buy rating on the stock. Alphabet shares rose 2.5% to $99.90 on Wednesday.
  • BMO Capital cut the price target for United Natural Foods, Inc. (NYSE:UNFI) from $45 to $40. BMO Capital analyst Kelly Bania maintained the stock with a Market Perform. United Natural Foods shares fell 3.3% to $36.10 on Wednesday.
  • Wedbush raised the price target on Biogen Inc. (NASDAQ:BIIB) from $183 to $217.. Biogen shares jumped 39.7% to $276.32 on Wednesday.
  • Deutsche Bank lowered the price target for Endava plc (NYSE:DAVA) from $94 to $78. Endava shares rose 6.4% to $82.60 on Wednesday.
  • EF Hutton cut the price target on BioVie Inc. (NASDAQ:BIVI) from $14 to $8. BioVie shares rose 5.1% to $2.48 on Wednesday.
  • Deutsche Bank raised the price target for Cracker Barrel Old Country Store, Inc. (NASDAQ:CBRL) from $100 to $106. Cracker Barrel shares fell 0.2% to $97.06 on Wednesday.
  • Baird boosted the price target on Ferguson plc (NYSE:FERG) from $132 to $140. Ferguson shares rose 3.5% to $106.79 on Wednesday.
  • Truist Securities下调目标价Alphabet公司(纳斯达克:谷歌)从145美元升至136美元。Truist Securities分析师优素福·斯夸利(Youssef Squali)维持对该股的买入评级。周三,Alphabet股价上涨2.5%,至99.90美元。
  • 蒙特利尔银行资本下调目标价联合天然食品公司(纽约证券交易所代码:FURI)从45美元到40美元。BMO Capital分析师凯利·巴尼亚(Kelly Bania)维持了该股的市场表现。联合自然食品股价周三下跌3.3%,至36.10美元。
  • 韦德布什将目标价上调至生物遗传公司纳斯达克:BIIB)从183美元涨至217美元。生物遗传研究公司的股价周三上涨39.7%,至276.32美元。
  • 德意志银行下调目标价Endava公司(纽约证券交易所代码:DAVA)从94美元升至78美元。Endava股价周三上涨6.4%,至82.60美元。
  • EF Hutton下调目标价BioVie Inc.(纳斯达克代码:BIVI)从14美元涨至8美元。BioVie股价周三上涨5.1%,至2.48美元。
  • 德意志银行上调目标价饼干桶老乡村商店,Inc.(纳斯达克:CBRL)从100美元到106美元。周三,Cracker Barrel股价下跌0.2%,至97.06美元。
  • Baird上调了目标价弗格森公司(纽约证券交易所股票代码:FERG)从132美元上涨到140美元。周三,弗格森的股价上涨3.5%,至106.79美元。

Check out this: These Analysts Boost Price Targets On Biogen Following Positive Alzheimer's Drug Data, Shares Jump

看看这个:在阿尔茨海默氏症药物数据积极后,这些分析师上调了Biogen的目标价,股价跳涨

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发